Miscellaneous vitreous-derived IgM antibodies target numerous retinal proteins in equine recurrent uveitis.

This research article investigates the role of Immunoglobulin M (IgM) antibodies in equine recurrent uveitis (ERU), an eye disease in horses. The researchers identified a wide immune response against various retina proteins, indicating an ongoing attack by the immune system that could be contributing to ERU’s recurring course.

Explanation of the Study

This study aimed to investigate the role of Immunoglobulin M (IgM) antibodies in Equine Recurrent Uveitis (ERU), a common eye disease in horses.

• The team of researchers sought to identify how IgM, a type of antibody, reacts with various proteins in the retinal area — a region of the eye affected by ERU.
• This was accomplished by separating the retina using gel electrophoresis, a process for separating proteins or nucleic acids, and blotting it onto PVDF membranes. These membranes were then incubated with vitreous samples from 50 ERU-affected horses and 30 healthy controls. These were probed for IgM antibodies.
• Subsequent examination of notable signals from the 2D western blot, a lab technique used to detect specific proteins, was mapped back to the 2D gel and examined using tandem mass spectrometry to identify the proteins.

Results and Conclusions

• The results showed that 68% of ERU vitreous samples had a great variety of IgM responses to various proteins in the retinal proteome. The responses were found at 17 different molecular weights, with the most frequent (found in 21 out of 50 samples) located at 49 kDa.
• In contrast, up to nine different signals were observed in a single sample when examining the samples between individuals, revealing a diverse array of responses. No IgM antibodies were found in samples from healthy horses.
• Further analysis identified 11 different proteins that were being targeted. However, one potential target could not be identified.
• This considerable IgM response to retina proteins may indicate an ongoing immune response. Such a mechanism might be contributing to the remitting relapsing character of ERU, meaning that the disease alternates between periods of flare-ups and remissions.
• The identification of new target proteins suggests that individual cases of ERU may have diverse response patterns, shedding more light on the complex nature of this disease.